Friday, October 30, 2026||
MultiKhabarMultiKhabar
Home/finance/Wells Fargo raises Eli Lilly stock price target on drug growth outlook

Wells Fargo raises Eli Lilly stock price target on drug growth outlook

In
Investing.com
By Investing.com
10/30/2026, 9:34:51 AM
Share:WhatsAppFacebookX (Twitter)Telegram
Wells Fargo raises Eli Lilly stock price target on drug growth outlook
EXECUTIVE SUMMARY

Wells Fargo raises Eli Lilly stock price target on drug growth outlook....

Key Takeaways

  • Wells Fargo raises Eli Lilly stock price target on drug growth outlook.

Share:WhatsAppFacebookX (Twitter)Telegram

Read Complete Original Article

Published originally on Investing.com

Visit Publisher Site →
OTHER MEDIA SOURCES COVERING THIS STORY
10 Publishers Reporting
Investing.com
Baird raises Spotify stock price target on subscriber growth outlook
Investing.com
Bernstein raises Northrop Grumman stock price target on growth outlook
Investing.com
Rosenblatt raises Palantir stock price target to $260 on AI growth
Investing.com
Truist raises Quanta Services stock price target on growth outlook
Investing.com
BTIG raises Guardant Health stock price target on growth outlook
Investing.com
BMO raises On Holding stock price target to $35 on sales outlook
Investing.com
Mizuho raises AxoGen stock price target to $65 on growth outlook
Investing.com
Stephens raises Regional Management stock price target on growth outlook
Investing.com
Truist raises Eli Lilly stock price target on obesity growth outlook

Related News

Multikhabar App

All Information In One Place

Real-time headlines from trusted sources. Get the app now — stay updated, inspired, and ahead with breaking news!

Get it on Google Play